Blandine L’Hirondel won the 2026 UTMB despite arterial endofibrosis. Learn how this vascular condition disrupts high-intensity training for endurance athletes.
On August 29, 2026, Blandine L’Hirondel won the women’s UTMB in 21:54:49. Her performance secured the fastest women’s time recorded on the 174-kilometre course. The grueling route features more than 9,000 metres of elevation gain. However, the 35-year-old French trail runner recently shared that a severe vascular condition completely derailed her race preparation.
In an interview with Le Monde, L’Hirondel stated that arterial endofibrosis in her left leg prevented her from completing intense training sessions. The condition severely compromised her preparation for the biggest race of the season. She also managed pain in her opposite leg from an injury sustained two months before the event. Three weeks before the starting gun, she admitted that even running 20 kilometres felt extremely difficult.
Her winning time was over twenty-one hours, securing her place ahead of American runner Rachel Entrekin, according to results coverage. L’Hirondel’s victory made her the first French woman in ten years to win the UTMB. It was a massive accomplishment that masked an incredibly difficult build-up.
L’Hirondel felt psychologically overwhelmed as the race approached. She shifted her pre-race goal from winning to simply finishing and enjoying the experience. She now plans to undergo surgery after the UTMB season and will not race again before the end of 2026.
Iliac artery endofibrosis is not the typical vascular disease associated with the natural aging process. Instead of conventional cholesterol and calcium plaque buildup, the artery supplying the leg develops abnormal thickening and narrowing. Dr. Margaret Tracci of UVA Health describes this condition as a repetitive-trauma injury. It primarily develops after the massive volume of repeated movements performed by dedicated endurance athletes.
The condition is observed frequently in athletes who repeatedly flex the hip. This group includes competitive cyclists, triathletes, and ultra-trail runners. The symptom pattern creates a frustrating illusion of poor conditioning or rapid fitness decline. Athletes might feel entirely capable during low-intensity, steady-state efforts.
However, they rapidly lose power or experience numbness when approaching maximal effort. Tracci notes that athletes often report burning, cramping, or tightening in the thigh or buttock. These localized symptoms can then progress downward toward the calf and foot. L’Hirondel’s own account provides a crucial athlete-level perspective on this precise physical toll.
The clinical understanding of this issue continues to evolve. Tracci’s explanation emphasizes that repeated hip flexion and high-volume movement can produce a distinct form of vascular trauma in susceptible endurance athletes. Her clinical description highlights an important performance distinction for runners and cyclists alike. An athlete might feel completely normal while jogging, but they will fail catastrophically when attempting to surge up a steep gradient.
This intensity-specific failure perfectly explains why L’Hirondel could still run easily but could not execute high-level preparation. A vascular condition of this nature interferes disproportionately with interval sessions, hill repetitions, and race-pace work. Easy running remains mechanically possible while heavy cardiovascular efforts become agonizing. It highlights a critical distinction between the ability to complete basic volume and the capacity to handle intense, race-specific training.
The difficulty in recognizing iliac endofibrosis stems from the highly specific athletic population it affects. Patients are typically very fit individuals whose symptoms only become apparent under extreme physical stress. UVA Health reported that its clinicians had diagnosed and treated more than 100 patients with iliac artery endofibrosis. When the affected artery shows significant thickening or narrowing, surgical treatment is often the required path forward.
According to Tracci, surgical interventions depend on the specific severity of the abnormality. Described surgical procedures include removing the abnormal tissue entirely and widening the artery with a patch. In some advanced cases, surgeons must replace the affected segment with a graft. The evidence assembled by clinical sources does not provide a universal recovery timeline following these operations.
There is no standard return-to-running protocol, nor is there a guaranteed performance outcome after surgery. Those critical decisions require highly individualized vascular and sports-medicine assessments. The available coverage indicates that treatment decisions are complex. Surgeons must carefully weigh the risks of operating on otherwise healthy athletes against the potential performance benefits.
Described procedures often require significant recovery periods, meaning an athlete's entire racing calendar must be adjusted. L’Hirondel’s decision to wait until the UTMB season ended reflects the disruptive nature of these surgical interventions. The terms used across coverage do not provide enough clinical detail to determine the precise anatomical location of L’Hirondel’s lesion. We only know its association with her left leg based on her public statements.
The condition should never be confused automatically with ordinary muscular fatigue, a lack of conditioning, or generalized aging-related arterial disease. The cited clinical explanation describes a distinct vascular process involving scar tissue and arterial narrowing. At the same time, the available sources do not provide population-level prevalence estimates for trail runners, masters athletes, or women aged 35 to 65. Claims that the condition is universally common, rapidly increasing, or especially prevalent in a particular age group would therefore be premature.
For ambitious older athletes, the immediate instinct is to push forcefully through any physical discomfort. We frequently blame a failed workout on poor sleep, heavy work stress, or natural age-related decline. However, treating recurring, intensity-specific leg symptoms as a mere lack of mental toughness is a dangerous mistake. The available evidence supports individualized, symptom-guided evaluation of masters athletes, including sport-specific testing and imaging when appropriate.
You must pay careful attention to unilateral thigh tightness, burning, or loss of power that repeatedly appears when your intensity rises. This proactive approach to health requires rethinking traditional weekly schedules to prioritize longevity. Hitting my forties brought a harsh reality check regarding how my own body responded to intensity. The track workouts were not getting slower, but the days after them felt significantly heavier.
Instead of forcing my old Tuesday and Thursday intensity schedule, I looked at the data on Masters athletes and muscle protein synthesis. I pushed my second hard session to Friday, allowing an extra forty-eight hours of low-intensity recovery. My total weekly volume stayed the same, but the quality of my intervals skyrocketed. That experience reinforced a core operating philosophy at Reendure.
You must consciously separate normal systemic fatigue from structural or vascular warning signs. If you cannot complete intense sessions due to localized cramping or numbness, start keeping a detailed symptom log. Record your precise pace, power output, gradient, and exactly how quickly the symptoms resolve. Take this organized data directly to a clinician familiar with endurance sports to rule out vascular disorders.
In many cases, executing strategic training reductions is necessary to preserve long-term health. The sources do not establish that every exercise-related leg pain symptom in an endurance athlete is vascular. Muscle injury, nerve irritation, exertional compartment syndrome, and other conditions can produce overlapping symptoms. This means thorough medical assessment is strictly necessary before making assumptions.
L’Hirondel built her UTMB race plan around her current functional capacity rather than an idealized training schedule. During the final quarter of the UTMB, she reported having little strength left on climbs. She experienced reduced confidence on the final descent and suffered several falls. She also noted increasing pain with each step near the finish line.
Despite those late-race difficulties, she won the highly competitive event. Her victory is remarkable, but it is an individual outcome rather than a broadly applicable medical recommendation. Winning a major ultramarathon despite limited high-intensity training is a rare exception. It does not demonstrate that arterial endofibrosis improves endurance performance in any capacity.
It also does not suggest that other older athletes would respond similarly to such a severe limitation. Your training plan must be grounded in physical reality, not just sheer willpower. We recommend modifying workout plans immediately if unexplained, one-sided leg pain consistently disrupts your high-intensity preparation.
Unexplained, unilateral leg pain during intense efforts demands professional medical evaluation rather than a stubborn refusal to modify your training plan.
Follow ReEndure for practical insights on endurance training, recovery, nutrition and healthy aging. Stay connected for new articles, research led guidance and ideas to help you perform better for longer.
Read practical ideas on endurance training, recovery, nutrition and healthy aging to keep progressing for years to come.
Read the Blog